Aller au contenu principal Activer le contraste adaptéDésactiver le contraste adapté
Plus de 40 000 produits accessibles à 0€ de frais de courtage
Découvrir Boursomarkets
Fermer

MEDTECH : MEDTECH ANNOUNCES SALE OF ROSA ROBOTIC SURGERY SYSTEM IN GERMANY
information fournie par Actusnews 22/09/2015 à 14:00

Montpellier, France, September 21, 2015 – MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, is pleased to announce a new sale of its ROSA™ robot to Frankfurt University Hospital in Germany.

Frankfurt University Hospital is one of the largest health establishments in Germany with more than 3,000 patients treated for neurological disorders per year. The neurosurgery department is of international renown and offers new approaches for the treatment of brain and spine diseases due to its commitment to equipping its patient care unit with the latest technology.

Bertin Nahum, CEO and Founder of Medtech said, “ Our recent entry into the German market is bearing its fruits as highlighted by this third ROSA™ system sale. There continues to be strong momentum in our global business and we are pleased with the acceleration in ROSA™ robot adoptions in Germany, Europe's No.1 market for medical equipment.”

About MEDTECH

Founded in 2002 by Bertin NAHUM and based near Montpellier, MEDTECH is a European specialist in the design, development and marketing of innovative robotic appliances to assist surgeons during their medico-surgical interventions, thus contributing to the implementation of safer, more efficient, less-invasive treatment.

In 2007, MEDTECH developed ROSA™, an innovative technological device devoted to brain surgery procedures. ROSA™ has been approved in Europe, the United States and Canada.

In 2013 Medtech received the “European Company of the Year Award” in the “robotic neurosurgery” category from Frost & Sullivan.

In July 2014, MEDTECH obtained the CE marking for its new product ROSA™ Spine, a robotic- assistive device for minimally invasive surgery of the spine.

In October 2014, MEDTECH won the “Révélation” prize in the Mediterranean Deloitte Technology Fast 50 Awards.
CONTACT MEDTECH
Christophe Sibillin
Chief Financial Officer
Tel : +33 (0)4 67 10 77 40
INVESTORS
Corinne Puissant
Tel : +33 (0)1 53 67 36 77
cpuissant@actus.fr
PRESS
Alexandra Prisa (EU) Joanna Zimmerman (US)
Tel. : +33(0)1 53 67 36 90 Tel : +1 646-536-7006
aprisa@actus.fr jzimmerman@theruthgroup.com

Information réglementée
Communiqués au titre de l'obligation d'information permanente :
- Activité de l'émetteur (acquisitions, cessions...)
Full and original press release in PDF:
http://www.actusnews.com/documents_communiques/ACTUS-0-41356-201509-MEDTECH-CP-Vente-Frankfurt-_ENG.pdf

Valeurs associées

50.00 EUR Euronext Paris 0.00%

0 commentaire

Signaler le commentaire

Fermer

Mes listes

Cette liste ne contient aucune valeur.